Financial Conflicts of Interest: Payment at the Expense of Patients? In the article that accompanies this editorial, Weisse et al 11 present new findings about residential hospice care for patients ...
Women diagnosed with hematological malignancies during pregnancy face higher severe maternal morbidity and obstetric complications compared to post-pregnancy diagnoses. The study analyzed data from ...
Fewer than 1% of all causes of ascites are attributed to conditions other than liver cirrhosis, cardiac disease or malignancy. In this case, the patient presented with massive splenomegaly and later ...
Early in 2024, we reported on the FDA's call for new boxed warnings on the labeling of all approved chimeric antigen receptor (CAR) T-cell therapies for the potential risk for secondary T-cell ...
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia. CAR T-cell therapy is a unique way of treating hematologic ...
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will share its latest research on hematologic malignancies and the prognostic effects of ...
Ivan Maillard, MD, PhD, has been appointed head of the division of hematologic malignancies at Memorial Sloan Kettering Cancer Center. Maillard is recognized for his expertise treating lymphoma and ...
Physical condition is the primary reason patients with blood cancers don’t receive treatment, followed by patient/family choice. In a new study, female patients were more likely than males to decline ...
The FDA recommends health care providers consider alternative therapies given the risks associated with Skysona. The Food and Drug Administration (FDA) is investigating additional reports of ...
Hematologic malignancy patients face high COVID-19 risk, with 23.5% experiencing severe illness despite vaccination. Mortality rate was 22.4%, influenced by age, active disease, and ICU admission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results